|
GNPDA1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.113800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.364700E-03 |
| Normal-vs-Stage2 |
1.521640E-01 |
| Normal-vs-Stage3 |
7.177800E-01 |
| Normal-vs-Stage4 |
7.261600E-01 |
| Stage1-vs-Stage2 |
4.868200E-01 |
| Stage1-vs-Stage3 |
4.551600E-02 |
| Stage1-vs-Stage4 |
4.121700E-02 |
| Stage2-vs-Stage3 |
1.608580E-01 |
| Stage2-vs-Stage4 |
1.630400E-01 |
| Stage3-vs-Stage4 |
9.998000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.322000E-02 |
| Normal-vs-AfricanAmerican |
1.974000E-02 |
| Normal-vs-Asian |
5.922400E-01 |
| Caucasian-vs-AfricanAmerican |
2.450400E-01 |
| Caucasian-vs-Asian |
3.102400E-01 |
| AfricanAmerican-vs-Asian |
5.479900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.296190E-02 |
| Normal-vs-Female |
3.495800E-01 |
| Male-vs-Female |
1.550650E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.581400E-01 |
| Normal-vs-Extreme_Weight |
4.379500E-03 |
| Normal-vs-Obese |
1.475220E-01 |
| Normal-vs-Extreme_Obese |
2.181200E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.691700E-02 |
| Normal_Weight-vs-Obese |
3.436600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.437800E-01 |
| Extreme_Weight-vs-Obese |
2.415000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.165400E-01 |
| Obese-vs-Extreme_Obese |
9.402600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.544800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.152600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.175200E-03 |
| Normal-vs-Age(81-100Yrs) |
2.721400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.724400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.571200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.252800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.658560E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.208800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.896200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.213300E-04 |
| Normal-VS-Type2 PRCC |
8.977500E-02 |
| Normal-VS-KIRP CIMP |
3.154500E-02 |
| Normal-VS-Unclassified PRCC |
7.534300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.19260000156041E-08 |
| Type1 PRCC-VS-KIRP CIMP |
9.949800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.361400E-03 |
| Type2 PRCC-VS-KIRP CIMP |
6.00039999999469E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
3.814300E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
1.787560E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.556800E-01 |
| Normal-vs-N1 |
9.219200E-01 |
| Normal-vs-N2 |
8.339200E-01 |
| N0-vs-N1 |
8.189600E-01 |
| N0-vs-N2 |
8.265000E-01 |
| N1-vs-N2 |
8.982800E-01 |
|
|
